Document:

Manufacturing Services Agreement

 EXHIBIT 10.10 
 Manufacturing Services Agreement 
 This Manufacturing Services Agreement
(“Agreement”) effective as of December 7, 2010. 
 Between UNICEP Packaging Inc, an Idaho USA company, with its registered office
at 1702 Industrial Drive Sandpoint ID 83864 (“UNICEP”) and Zeltiq Aesthetics with its registered office at 4698 Willow Road, Pleasanton, CA 94588 (“ZELTIQ”) 
 Where appropriate, ZELTIQ and UNICEP are hereinafter collectively referred to as “Parties” and individually referred to as “a Party”. 

Whereas, ZELTIQ is in the business of the development of non-invasive procedures for the reduction of unwanted fat tissue and requires production and
assembly of Gelpads. 
 Whereas UNICEP is in the business of contract gel manufacturing and provider of packaging services 

Whereas, ZELTIQ wishes to engage UNICEP to manufacture the ZELTIQ Gelpad. 

  
 1 

 Now therefore, the Parties agree as follows: 
 1 Purpose 
 1.1 This Agreement shall cover the sale of Products by UNICEP to
ZELTIQ as defined in the Purchase Order by ZELTIQ. 
 2 Forecasts 
 2.1 Periodically (but no less frequently than monthly), ZELTIQ shall deliver to UNICEP (via e-mail or other mutually agreed upon manner) a Forecast. This Forecast will indicate volumes and the
requested delivery date of the manufactured Products for the next 12 months period and is intended to assist UNICEP in planning and Component management purposes. 
 2.2 UNICEP shall maintain sufficient manufacturing capacity to permit it to deliver the Products to the ZELTIQ in accordance with the applicable Purchase Orders. 

3 Purchase Orders 
 3.1 ZELTIQ
will provide to UNICEP binding Purchase Orders taking into account a lead-time of 16 weeks. 
 3.2 UNICEP shall not unreasonably refuse
acceptance of any Purchase Order. 
 3.3 ZELTIQ may issue Purchase Orders for Product in excess of the Forecast, which will be accepted
by UNICEP, provided that UNICEP can obtain the necessary Components. In the event UNICEP’s Component unavailability prevents UNICEP from committing to the requested delivery date, UNICEP will provide notice to ZELTIQ within ten
(10) business days and at that time the parties will mutually agree on a revised delivery date. If UNICEP does not provide such notice within ten (10) business days then the applicable Purchase Order will be deemed accepted. 

3.4 ZELTIQ may increase, reschedule, or cancel the quantity of any Products specified in a Purchase Order by delivering to UNICEP, by email, mail
or facsimile, a written Change Order. No Change Order shall be effective until it is actually received and accepted by UNICEP’s authorized representative. Receipt notice and acceptance (or rejection, regarding an increase, due to UNICEP’s
inability to obtain the necessary Components) shall be provided to ZELTIQ within ten (10) business days. If UNICEP does not provide such notice within ten (10) business days then the applicable Purchase Order will be deemed accepted.

 3.5 ZELTIQ agrees it is liable to take title to and pay for all quantities of Products reflected on ZELTIQ Purchase Orders; unless a
Change Order has been forwarded by ZELTIQ and accepted by UNICEP. At time of acceptance the Change Order shall govern. 
 3.6 In the
event that UNICEP purchases and receives material for Purchase Orders accepted by UNICEP hereunder, and ZELTIQ requests and UNICEP agrees to cancellation or rescheduling of such Purchase Order then UNICEP shall notify ZELTIQ of (i) the cost of
the relevant materials including raw materials, work in process, finished goods, excess and obsolete materials that UNICEP has obtained specifically to fulfill ZELTIQ Purchase Orders and cannot use because of such cancellation or rescheduling
(collectively referred to as “Inventories”) and (ii) the cost of the Inventories. 

  
 2 

 3.7 After receiving the cost of the Inventories from UNICEP pursuant to Section 3.6 with respect
to a cancelled or rescheduled Purchase Order, if ZELTIQ elects to continue with the applicable cancellation or rescheduling then ZELTIQ agrees it is responsible for all costs and expenses and the stated cost of the Inventories associated with the
changes, cancellation or rescheduling of such Purchase Order. 
 3.8 In the event of a cancellation of a Purchase Order as described in
Section 3.6 all Inventories including but not limited to completed Products, assemblies in process, components and any tooling, test and burn-in equipment owned by ZELTIQ and furnished to UNICEP, shall be disposed of or handled at ZELTIQ’s
expense in accordance with written instructions furnished by the ZELTIQ. 
 3.9 Purchase Obligation. All quantities are as set
forth in the Purchase Order or by separate written agreement. ZELTIQ agrees to purchase all Inventories including excess inventory that UNICEP has obtained or manufactured specifically to fulfill ZELTIQ orders (including, without limitation, all
non-returnable minimum purchase quantities, tape and reel, tube and tray items, and all customized non-returnable items or items that are purchased at volumes to maintain pricing that exceed the current Purchase Order demand) (the “Excess
Inventory”) upon receipt of an invoice from UNICEP. 
 UNICEP will provide to ZELTIQ on a monthly basis a report of all Inventories
including excess inventory that UNICEP has obtained or manufactured specifically to fulfill ZELTIQ orders. 
 4 Delivery & Shipping

 4.1 Acceptance Testing. ZELTIQ will have the right but not the obligation to conduct or have conducted acceptance testing on
all Product deliveries. Within ten (10) business days after ZELTIQ’s receipt of the Product, ZELTIQ will provide UNICEP with a written statement detailing the manner in which the Product has failed to conform to this Agreement and mutually
agreed specifications (which specifications include IPC Standards. ZELTIQ’s failure to so notify UNICEP within such time period shall constitute acceptance of the Products. If the Product delivered hereunder fails to conform to the Agreement,
the mutually agreed specifications, or to such other testing and acceptance criteria as may be mutually agreed upon by the parties in writing (collectively, “Specifications”), ZELTIQ shall notify UNICEP in writing of such failure,
detailing the nature of the alleged failure, and the parties will promptly discuss means to resolve any such failure. UNICEP shall then deliver to ZELTIQ, pursuant to an agreed-upon schedule, but in no event in greater than fifteen
(15) business days after (i) ZELTIQ’s notice of the failure, or (ii) if ZELTIQ is required to provide the components necessary to make the Product, after ZELTIQ has provided UNICEP with the component materials required to
manufacture the Products, Products that conform to the Specifications. Upon re-delivery, ZELTIQ shall have an additional ten (10) business day period to conduct acceptance testing on the applicable Product and provide a written statement
detailing the manner in which the Product has failed to conform to the Specifications. 
 4.2 Delivery. Products are deemed
accepted by ZELTIQ as specified in Section 4.1. No returns may be made for any reason without a Returned Material Authorization (“RMA”) number issued by UNICEP; provided that UNICEP shall issue RMA numbers for Products eligible for
return under Section 4.1 or Section 6. If UNICEP fails to meet the delivery date specified on a Purchase Order accepted by Unicep, then UNICEP shall 

  
 3 

 
ship the applicable Products via express delivery and be responsible for paying any express delivery rates applicable to shipment that are above and beyond typical shipment methods of the
Products at issue. 
 4.3 Shipping Terms. In the absence of prior agreement as to shipping, UNICEP may select a carrier. Shipping
terms are F.O.B.: UNICEP Shipping Point. UNICEP’ responsibility for any loss or damage ends, and title passes, when products are delivered to the carrier, to ZELTIQ, or to ZELTIQ’s agent, whichever occurs first. ZELTIQ will pay for storage
charges if products are held by UNICEP at ZELTIQ’s request pending instructions or rescheduled delivery. 
 5.0 Prices - Invoicing -
Payment Terms 
 5.1 Pricing Terms. Pricing is based on kit quantities as quoted to ZELTIQ, which may be updated
and amended from time to time upon written agreement of the parties. If ZELTIQ requires UNICEP to purchase components for the Products from vendors on an Authorized Vendor List (“AVL”) specified by ZELTIQ, all price increases with respect
to the components purchased from vendors on the AVL are the responsibility of ZELTIQ and ZELTIQ agrees to pay for any such increases upon thirty (30) days prior written notice from UNICEP. Prices do not include any taxes, freight, handling,
duty or other charges, payment of which will be the sole responsibility of ZELTIQ. ZELTIQ agrees to assume all tooling costs and expenses that are pre-approved by ZELTIQ and unique to the assembly or testing of ZELTIQ’s products. ZELTIQ
supplied equipment shall perform as expected to achieve cycle times similar to those outlined in Quote 125GB, and any major issues around performance of the equipment are responsibility of ZELTIQ. Routine maintenance costs for tooling and equipment
associated with the assembly or test of ZELTIQ’s products is UNICEP’s responsibility. Prices are conditioned upon timely payment and any past due balance will accrue interest at the monthly rate of one and one-half percent
(1 1/2%). 

5.2 Payment Terms. Terms of payment are net 30 days from invoice date to be paid by way of electronic transfer. All pre-approved non-recurring
engineering charges are payable upon receipt of invoice. UNICEP reserves the right to modify payment terms prior to shipment, require payment in advance or delay or cancel any shipment or order by reason of ZELTIQ’s creditworthiness or should
ZELTIQ fail to fulfill any material obligation when due. 
 6 Warranties 
 6.1 Performance Warranty. UNICEP warrants that those Products assembled or customized by it shall be free from defects caused solely by faulty assembly or customization and shall conform to the
Specifications for 360 days after delivery. All other products and the components and materials utilized in any assembled or customized products, in each case ZELTIQ requires UNICEP to purchase from the AVL unless otherwise instructed in writing by
ZELTIQ and agreed to by UNICEP, are covered by, and subject to, the terms, conditions, and limitations of the manufacturer’s standard warranty which warranty is expressly in lieu of any other warranty, express or implied, of or by UNICEP or the
manufacturer. ZELTIQ’s exclusive remedy, if any, under these warranties is limited, at UNICEP’s election, to any one of (b) repair by UNICEP or the manufacturer of any Products found to be defective, or (c) replacement of any
such Product. ZELTIQ acknowledges that except as specifically set forth or referenced in this 

  
 4 

 
paragraph, THERE ARE NO REPRESENTATIONS OR WARRANTIES OF ANY KIND (INCLUDING, WITHOUT LIMITATION, IN ADVERTISING MATERIALS, BROCHURES, OR OTHER DESCRIPTIVE LITERATURE) BY UNICEP OR ANY OTHER
PERSON, EXPRESS OR IMPLIED, AS TO THE CONDITION OR PERFORMANCE OF ANY PRODUCTS, THEIR MECHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE, OR OTHERWISE. UNICEP ASSUMES NO RESPONSIBILITY OR LIABILITY WHATSOEVER FOR MANUFACTURER’S PRODUCT
SPECIFICATIONS OR THE PERFORMANCE OR ADEQUACY OF ANY DESIGN OR SPECIFICATION PROVIDED TO UNICEP BY OR ON BEHALF OF ZELTIQ. 
 6.2 Compliance
with Laws. UNICEP represents and warrants that UNICEP complies with all applicable laws, rules, regulations, health and safety requirements as it applies to the assembly of the Products. 
 6.3 Quality Agreement 
 A separate Quality Agreement supplements this document relating to
the quality aspects of this agreement. 
 6.4 No Liens, Claims or Encumbrances. UNICEP represents and warrants to ZELTIQ that at the time of
delivery to ZELTIQ all Products shall be free of any securities interest or any other lien, claim or other encumbrance whatsoever. 
 7.
Period Termination 
 7.1 This Agreement shall commence on the Effective Date for an indefinite term. Beginning eighteen (18) months
after the Effective Date, either party may terminate the Agreement for any reason by giving six (6) months advance written notice. In the event of a termination by UNICEP for reasons of convenience, UNICEP agrees to satisfy and fulfill Purchase
Orders accepted prior to the termination date and agrees to reasonably commercially support ZELTIQ transition to alternative sources. In the event of a termination by ZELTIQ for reasons of convenience, ZELTIQ agrees to pay UNICEP for all finished
goods that are subject to accepted Purchase Orders (“Finished Goods”), work in process (“WIP”), raw materials (“Raw Materials”), open orders with vendors (“Supply”), and Excess
Inventory, in each case, that UNICEP has obtained or manufactured specifically to fulfill ZELTIQ orders and that UNICEP cannot redeploy after such termination (the amount of such payment being the (“ZELTIQ Expense”). The ZELTIQ
Expense shall be determined by UNICEP based upon (a) the prices for Finished Goods set forth in the relevant Purchase Orders and (b) the cost of WIP, Raw Materials, Supply, and Excess Inventory plus a 15% handling charge. At UNICEP’
option, UNICEP will either ship the Finished Goods, WIP, Raw Materials, Supply and Excess Inventory to ZELTIQ upon receipt of full payment of the ZELTIQ Expense or on a COD basis. UNICEP reserves the right to charge ZELTIQ a monthly inventory
holding fee of 2% of the ZELTIQ Expense. UNICEP shall provide ZELTIQ an itemized invoice that details the cost of each element of the ZELTIQ Expense. 
 7.2 A Party may terminate this Agreement for cause if the other Party materially breaches this Agreement and does not cure such breach within thirty (30) days after the breaching Party receives
notice of the breach from the non-breaching Party. 

  
 5 

 7.3 For the sake of clarity, Zeltiq under any circumstances is responsible for Inventories as defined in 3.7
of this Agreement. 
 8 Confidentiality 
 8.1 “Confidential Information” shall mean non-public information that is disclosed by either party to the other party pursuant to this Agreement, including product specifications and
technical and other documentation, business and product plans and other confidential business information whether in written, graphic, electronic or oral form. Confidential Information shall not include information which: (i) is or becomes
public knowledge without any action by, or involvement of, the receiving party; (ii) is disclosed by the receiving party with the specific, prior written approval of the disclosing party; (iii) is independently developed by the receiving
Party without use of the disclosing party’s Confidential Information; or (iv) is rightfully received by the receiving party from a third party without a duty of confidentiality. 
 8.2 Nondisclosure. All Confidential Information exchanged between UNICEP and ZELTIQ pursuant to this Agreement shall be maintained as confidential and shall not be distributed, disclosed, or
disseminated in any way or form by the receiving party to anyone except its own employees and agents who have a reasonable need to know such Confidential Information and who have been advised of the confidential nature and required to observe the
terms and conditions hereof; nor shall Confidential Information be used by the receiving party for any purpose other than exercising its rights or fulfilling its obligations under this Agreement. 

8.3 Legal Obligation to Disclose. This Agreement will not prevent the receiving party from disclosing Confidential Information of the disclosing
party to the extent required by a judicial order or other legal obligation, provided that, in such event, the receiving party shall promptly notify the disclosing party prior to disclosure to allow intervention, notify the requesting entity of the
confidentiality of the materials, and cooperate with the disclosing party to contest or minimize the scope of the disclosure (including application for a protective order). 
 8.4 Return of Confidential Information. Upon request of the disclosing party, copies and embodiments of the disclosing party’s Confidential Information shall be promptly returned to the
disclosing party by the receiving party. Upon termination of this Agreement, for any reason, each party shall promptly return to the other party all Confidential Information provided by the other party, including all copies thereof. 

9 INDEMNIFICATION. 
 UNICEP shall, at its expense, defend, indemnify and hold ZELTIQ and its officers, directors, employees and agents harmless from and against any liabilities, losses, damages, costs and expenses, including,
without limitation, reasonable attorneys’ fees, arising from or related to any third party claim, action, suit or proceeding (“Claim”) arising from the following: (i) from the failure or alleged failure of the Products to
comply with the mutually agreed in writing Specifications that are a result of improper assembly; or (ii) alleging that UNICEP’S manufacturing processes infringe any third party Intellectual Property Rights not specified by ZELTIQ. ZELTIQ
will promptly notify UNICEP in writing of any such Claims and give UNICEP control over the defense or settlement of such Claims, provided, however, that (a) the failure to provide prompt 

  
 6 

 
notice shall not relieve UNICEP of its indemnity obligations hereunder except to the extent that the delay in providing notice prejudices the defense of such Claims, and (b) ZELTIQ shall
have the right to participate in the defense of such Claims at its expense. UNICEP shall not settle, or consent to any entry of judgment with respect to, any such Claims without obtaining either (x) an unconditional release of ZELTIQ (and its
officers, directors, employees and agents) from all liability with respect to such Claims, or (y) the prior written consent of ZELTIQ. ZELTIQ will make available to UNICEP any books or records in ZELTIQ’s possession that are necessary to
the defense of any such Claims. 
 10. LIMITED LIABILITY. EXCEPT FOR ANY AMOUNTS REQUIRED PURSUANT TO THE
OBLIGATIONS OF INDEMNIFICATION HEREUNDER, OR DAMAGES ARISING FROM A BREACH BY A PARTY OF SECTION 8, NEITHER PARTY WILL BE LIABLE TO THE OTHER PARTY FOR ANY LOST PROFITS OR FOR ANY CONSEQUENTIAL, SPECIAL OR INCIDENTAL DAMAGES SUFFERED BY THE OTHER
PARTY ARISING OUT OF OR RELATED TO THIS AGREEMENT. 
 11 Insurance. UNICEP shall maintain, during the term of the Agreement and for one
(1) year thereafter, (i) a general liability insurance policy with coverage for Completed Products, issued by an insurer with an “A” rating, which shall name ZELTIQ, including any parent company, subsidiaries, affiliates, owners,
stockholders, directors, officers, employees, agents, representatives, heirs, successors, and assigns (the “Insured Parties”) as additional insureds against any and all demands, claims, suits, causes of action, whether at law or in
equity, and/or liability to anyone for any injuries to their person, or property, arising out of a defect in the Products (the “Product Liability Policy”); and (ii) a property insurance policy, issued by an insurer with an
“A” rating, which shall name the Insured Parties as additional Loss Payees to cover the loss, destruction or theft of any of the ZELTIQ Materials (the policies collectively referred to as the “Manufacturer Policies”). The
coverage for the Product Liability Policy shall be not less than one million dollars ($1,000,000.00) per occurrence, combined single-limit bodily injury and property damage, and not less than two million dollars ($2,000,000.00) in the aggregate.
UNICEP Policies shall provide for not less than thirty (30) days advance written notice to ZELTIQ of a cancellation or termination of the UNICEP Policies, of a reduction of UNICEP Policies’ limits, or of any other material change in UNICEP
Policies. Within thirty (30) days after the execution of this Agreement, ONCORFE shall deliver to ZELTIQ a certificate of insurance confirming the existence or issuance of the UNICEP Policies. 

12 Construction. Any addition or change to the terms of this Agreement must be specifically agreed to in writing by a duly authorized officer of
UNICEP and ZELTIQ before becoming binding. In the event of any conflict between the terms of this Agreement and the terms of the Purchase Order, the terms of this Agreement shall govern. 
 13 Force Majeure 
 UNICEP will not be liable for any failure or delay in its performance or
in the delivery or shipment of product, or for any damages suffered by ZELTIQ by reason of such failure or delay, when such failure or delay is caused by, or arises in connection with, any fire, flood, accident, riot, earthquake, severe weather,
war, governmental interference or embargo, strike, shortage of labor, fuel, power, or any other cause or causes beyond UNICEP’ reasonable control. Each Party reserves the right to cancel without liability any

  
 7 

 
order, with the exception of Section 3.10, the shipment of which is or may be delayed for more than 30 days by reason of any such cause. UNICEP reserves the right to allocate in its sole
discretion among ZELTIQ’s or potential ZELTIQ S’s, or defer or delay the shipment of, any product which is in short supply. 
 14
Survival 
 The rights and obligations of the parties hereto under the provisions of Confidentiality (Section 8) and the Nondisclosure
Agreement dated August 28, 2008 shall survive expiration or termination of this Agreement and shall remain in full force and effect for a period of five (5) years following the expiration or termination of this Agreement. 

15 Governing Law – Jurisdiction 

This Agreement shall in all respects be governed by the law of California USA. 
 16 Severability. If for any reason a court of competent jurisdiction finds any provision of this Agreement to be unenforceable, that provision of the Agreement shall be enforced to the maximum
extent permissible so as to effect the intent of the parties, and the remainder of this Agreement will continue in full force and effect. 
 17.
Relationship of the Parties. Neither execution nor performance of this Agreement will be construed to have established any agency, joint venture, or partnership relationship between the parties. 

  
 8 

 18 Enforceable Contract. ZELTIQ acknowledges and represents that it is a sophisticated party in the
Medical Device manufacturing industry, that it has read and understood all of the terms and conditions of this Agreement and understands and agrees that this Agreement constitutes a legally enforceable contract. 

 

					
	UNICEP	 		  	ZELTIQ
			
	 /s/ Clint J. Marshall
	 		  	 /s/ Rick Poinsett

	By:	 		  	By:
	 CFO, VP of Business Development
	 		  	 VP RISC

	Title:	 		  	Title:
	 Clint J. Marshall
	 		  	 Rick Poinsett

	Name:	 		  	Name:

  
 9Form of Indemnification Agreement

 EXHIBIT 10.17 
 INDEMNITY AGREEMENT 
 This Indemnity Agreement, dated
[            ], 2011, is made between ZELTIQ Aesthetics, Inc., a Delaware corporation (the “Company”), and
[                    ] (the “Indemnitee”). 
 RECITALS 
 A. The Company desires to attract and retain the services of
talented and experienced individuals, such as Indemnitee, to serve as directors and officers of the Company and its subsidiaries and wishes to indemnify its directors and officers to the maximum extent permitted by law; 

B. The Company and Indemnitee recognize that corporate litigation in general has subjected directors and officers to expensive litigation
risks; 
 C. Section 145 of the General Corporation Law of Delaware, under which the Company is organized
(“Section 145”), empowers the Company to indemnify its directors and officers by agreement and to indemnify persons who serve, at the request of the Company, as the directors and officers of other corporations or enterprises,
and expressly provides that the indemnification provided by Section 145 is not exclusive; 
 D. Section 145(g) allows
for the purchase of management liability (“D&O”) insurance by the Company, which in theory can cover asserted liabilities without regard to whether they are indemnifiable or not; 

E. Individuals considering service or presently serving expect to be extended market terms of indemnification commensurate with their
position, and that entities such as Company will endeavor to maintain appropriate D&O insurance; and 
 F. In order to
induce Indemnitee to serve or continue to serve as a director or officer of the Company and/or one or more subsidiaries of the Company, the Company and Indemnitee enter into this Agreement. 

AGREEMENT 

NOW, THEREFORE, the Indemnitee and the Company hereby agree as follows: 

1. Definitions. As used in this Agreement: 
 (a) “Agent” means any person who is or was a director, officer, employee or other agent of the Company or a subsidiary of the Company; or is or was serving at the request of, for the
convenience of, or to represent the interests of the Company or a subsidiary of the Company as a director, officer, employee or agent of another foreign or domestic corporation, partnership, joint venture, trust or other enterprise; or was a
director, officer, employee or agent of a foreign or domestic corporation which was a predecessor corporation of the Company or a subsidiary of the Company, or was a director, officer, employee or agent of another enterprise at the request of, for
the convenience of, or to represent the interests of such predecessor corporation. 

  
 1 

 (b) “Board” means the Board of Directors of the Company. 

(c) A “Change in Control” shall be deemed to have occurred if (i) any “person,” as such term is used in
Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned directly or
indirectly by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company, is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly,
of securities of the Company representing a majority of the total voting power represented by the Company’s then outstanding voting securities, (ii) during any period of two consecutive years, individuals who at the beginning of such
period constituted the Board, together with any new directors whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either
were directors at the beginning of the period or whose election or nomination was previously so approved, cease for any reason to constitute a majority of the Board, (iii) the stockholders of the Company approve a merger or consolidation or a
sale of all or substantially all of the Company’s assets with or to another entity, other than a merger, consolidation or asset sale that would result in the holders of the Company’s outstanding voting securities immediately prior thereto
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least a majority of the total voting power represented by the voting securities of the Company or such surviving or
successor entity outstanding immediately thereafter, or (iv) the stockholders of the Company approve a plan of complete liquidation of the Company. 
 (d) “Expenses” shall include all out-of-pocket costs of any type or nature whatsoever (including, without limitation, all attorneys’ fees and related disbursements), actually and
reasonably incurred by the Indemnitee in connection with either the investigation, defense or appeal of a Proceeding or establishing or enforcing a right to indemnification under this Agreement, or Section 145 or otherwise; provided, however,
that “Expenses” shall not include any judgments, fines, ERISA excise taxes or penalties, or amounts paid in settlement of a Proceeding. 
 (e) “Independent Counsel” means a law firm, or a partner (or, if applicable, member) of such a law firm, that is experienced in relevant matters of corporation law and neither currently
is, nor in the past five years has been, retained to represent: (i) the Company or the Indemnitee in any matter material to either such party or (ii) any other party to or witness in the proceeding giving rise to a claim for
indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in
representing either the Company or the Indemnitee in an action to determine the Indemnitee’s rights under this Agreement. 

  
 2 

 (f) “Proceeding” shall mean any threatened, pending, or completed action,
claim, suit, arbitration, alternate dispute resolution mechanism, investigation, administrative hearing or any other proceeding whether formal or informal, civil, criminal, administrative, or investigative, including any such investigation or
proceeding instituted by or on behalf of the Corporation or its Board of Directors, in which Indemnitee is or reasonably may be involved as a party or target, that is associated with Indemnitee’s being an Agent of the Corporation. 

(g) “Subsidiary” means any corporation of which more than 50% of the outstanding voting securities is owned directly or
indirectly by the Company, by the Company and one or more other subsidiaries, or by one or more other subsidiaries. 
 2.
Agreement to Serve. The Indemnitee agrees to serve and/or continue to serve as an Agent of the Company, at its will (or under separate agreement, if such agreement exists), in the capacity the Indemnitee currently serves as an Agent of the
Company, so long as the Indemnitee is duly appointed or elected and qualified in accordance with the applicable provisions of the Bylaws of the Company or any subsidiary of the Company or until such time as the Indemnitee tenders his or her
resignation in writing; provided, however, that nothing contained in this Agreement is intended to create any right to continued employment by the Indemnitee. 
 3. Liability Insurance. 
 (a) Maintenance of D&O Insurance. The
Company hereby covenants and agrees that, so long as the Indemnitee shall continue to serve as an Agent of the Company and thereafter so long as the Indemnitee shall be subject to any possible Proceeding by reason of the fact that the Indemnitee was
an Agent of the Company, the Company, subject to Section 3(c), shall promptly obtain and maintain in full force and effect directors’ and officers’ liability insurance (“D&O Insurance”) in reasonable amounts from
established and reputable insurers, as more fully described below. In the event of a Change in Control, the Company shall, as set forth in Section (c) below, either: i) maintain such D&O Insurance for six years; or ii) purchase a six year
tail for such D&O Insurance. 
 (b) Rights and Benefits. In all policies of D&O Insurance, the Indemnitee shall
qualify as an insured in such a manner as to provide the Indemnitee the same rights and benefits as are accorded to the most favorably insured of the Company’s independent directors (as defined by the insurer) if the Indemnitee is such an
independent director; of the Company’s non-independent directors if the Indemnitee is not an independent director; of the Company’s officers if the Indemnitee is an officer of the Company; or of the Company’s key employees, if the
Indemnitee is not a director or officer but is a key employee. 
 (c) Limitation on Required Maintenance of D&O
Insurance. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain D&O Insurance at all, or of any type, terms, or amount, if the Company determines in good faith that: such insurance is not reasonably
available; the premium costs for such insurance are disproportionate to the amount of coverage provided; the coverage provided by such insurance is limited so as to provide an insufficient or unreasonable benefit; the Indemnitee is covered by
similar insurance maintained by a subsidiary of the Company; the Company is to be acquired and a tail policy of 

  
 3 

 
reasonable terms and duration can be purchased for pre-closing acts or omissions by the Indemnitee; or the Company is to be acquired and D&O Insurance can be maintained by the acquirer that
covers pre-closing acts and omissions by the Indemnitee. 
 4. Mandatory Indemnification. Subject to the terms of this
Agreement: 
 (a) Third Party Actions. If the Indemnitee is a person who was or is a party or is threatened to be made a
party to any Proceeding (other than an action by or in the right of the Company) by reason of the fact that the Indemnitee is or was an Agent of the Company, or by reason of anything done or not done by the Indemnitee in any such capacity, the
Company shall indemnify the Indemnitee against all Expenses and liabilities of any type whatsoever (including, but not limited to, judgments, fines, ERISA excise taxes and penalties, and amounts paid in settlement) actually and reasonably incurred
by the Indemnitee in connection with the investigation, defense, settlement or appeal of such Proceeding, provided the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of
the Company, and, with respect to any criminal action or Proceeding, had no reasonable cause to believe his or her conduct was unlawful. 
 (b) Derivative Actions. If the Indemnitee is a person who was or is a party or is threatened to be made a party to any Proceeding by or in the right of the Company by reason of the fact that the
Indemnitee is or was an Agent of the Company, or by reason of anything done or not done by the Indemnitee in any such capacity, the Company shall indemnify the Indemnitee against all Expenses actually and reasonably incurred by the Indemnitee in
connection with the investigation, defense, settlement or appeal of such Proceeding, provided the Indemnitee acted in good faith and in a manner the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; except
that no indemnification under this Section 4(b) shall be made in respect to any claim, issue or matter as to which the Indemnitee shall have been finally adjudged to be liable to the Company by a court of competent jurisdiction unless and only
to the extent that the Delaware Court of Chancery or the court in which such Proceeding was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, the Indemnitee is
fairly and reasonably entitled to indemnity for such amounts which the Delaware Court of Chancery or such other court shall deem proper. 
 (c) Actions where Indemnitee is Deceased. If the Indemnitee is a person who was or is a party or is threatened to be made a party to any Proceeding by reason of the fact that the Indemnitee is or
was an Agent of the Company, or by reason of anything done or not done by the Indemnitee in any such capacity, and if, prior to, during the pendency of or after completion of such Proceeding the Indemnitee is deceased, the Company shall indemnify
the Indemnitee’s heirs, executors and administrators against all Expenses and liabilities of any type whatsoever to the extent the Indemnitee would have been entitled to indemnification pursuant to this Agreement were the Indemnitee still
alive. 
 (d) Certain Terminations. The termination of any Proceeding or of any claim, issue, or matter therein by
judgment, order, settlement, or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself create a presumption that the Indemnitee did not act
in good faith and in a manner which the Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal action or Proceeding, that the Indemnitee had reasonable cause to believe that the
Indemnitee’s conduct was unlawful. 

  
 4 

 (e) Limitations. Notwithstanding the foregoing, the Company shall not be obligated to
indemnify the Indemnitee for Expenses or liabilities of any type whatsoever for which payment is actually made to or on behalf of the Indemnitee under an insurance policy, or under a valid and enforceable indemnity clause, by-law or agreement.

 (f) Witness. In the event that Indemnitee is not a party or threatened to be made a party to a Proceeding, but is
subpoenaed in such a Proceeding by reason of the fact that the Indemnitee is or was an Agent of the Company, or by reason of anything witnessed by the Indemnitee in that capacity, the Company shall indemnify the Indemnitee against i) all
out-of-pocket costs of any type or nature whatsoever (including, without limitation, all attorneys’ fees and related disbursements), actually and reasonably incurred by the Indemnitee in responding to such subpoena; and ii) if Indemnitee is a
former Agent of the Company at that time and is employed elsewhere, reasonable reimbursement for Indemnitee’s time spent testifying and meeting with Company counsel prior to such testimony solely to prepare for such testimony, at a rate based
on Indemnitee’s compensation at such employment, but not to exceed $900 per hour. 
 5. Indemnification for Expenses in
a Proceeding in Which the Indemnitee is Wholly or Partly Successful. 
 (a) Successful Defense. Notwithstanding any
other provisions of this Agreement, to the extent the Indemnitee has been successful, on the merits or otherwise, in defense of any Proceeding (including, without limitation, an action by or in the right of the Company) in which the Indemnitee was a
party by reason of the fact that the Indemnitee is or was an Agent of the Company at any time, the Company shall indemnify the Indemnitee against all Expenses actually and reasonably incurred by or on behalf of the Indemnitee in connection with the
investigation, defense or appeal of such Proceeding. 
 (b) Partially Successful Defense. Notwithstanding any other
provisions of this Agreement, to the extent that the Indemnitee is a party to any Proceeding (including, without limitation, an action by or in the right of the Company) in which the Indemnitee was a party by reason of the fact that the Indemnitee
is or was an Agent of the Company at any time and is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify the Indemnitee against all Expenses actually
and reasonably incurred by or on behalf of the Indemnitee in connection with each successfully resolved claim, issue or matter. 

(c) Dismissal. For purposes of this section and without limitation, the termination of any claim, issue or matter in such a
Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 
 (d) Contribution. If the indemnification provided in this Agreement is unavailable and may not be paid to Indemnitee for any reason other than statutory limitations, then in respect of any
threatened, pending or completed action, suit or proceeding in which the 

  
 5 

 
Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), the Company shall contribute to the amount of expenses (including attorneys’ fees),
judgments, fines and amounts paid in settlement actually and reasonably incurred and paid or payable by Indemnitee in such proportion as is appropriate to reflect (i) the relative benefits received by the Company on the one hand and Indemnitee
on the other hand from the transaction from which such action, suit or proceeding arose, and (ii) the relative fault of Company on the one hand and of Indemnitee on the other in connection with the events which resulted in such expenses,
judgments, fines or settlement amounts, as well as any other relevant equitable considerations. The relative fault of the Company on the one hand and of Indemnitee on the other shall be determined by reference to, among other things, the
parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent the circumstances resulting in such expenses, judgments, fines or settlement amounts. The Company agrees that it would not be just and equitable
if contribution pursuant to this section were determined by pro rata allocation or any other method of allocation which does not take account of the foregoing equitable considerations. 

6. Mandatory Advancement of Expenses. Subject to the terms of this Agreement and following notice pursuant to Section 7(a)
below, the Company shall advance all Expenses reasonably incurred by the Indemnitee in connection with the investigation, defense, settlement or appeal of any Proceeding to which the Indemnitee is a party or is threatened to be made a party by
reason of the fact that the Indemnitee is or was an Agent of the Company (unless there has been a final determination that the Indemnitee is not entitled to indemnification for such Expenses) upon receipt satisfactory documentation supporting such
Expenses. By execution of this Agreement, Indemnitee agrees to repay the amount advanced only in the event and to the extent that it shall ultimately be determined that the Indemnitee is not entitled to indemnification by the Company to the extent
set forth in this agreement and under Delaware law. Such advances are intended to be an obligation of the Company to the Indemnitee hereunder and shall in no event be deemed to be a personal loan. Such advancement of Expenses shall otherwise be
unsecured and without regard to Indemnitee’s ability to repay. The advances to be made hereunder shall be paid by the Company to the Indemnitee within twenty (20) days following delivery of a written request therefore by the Indemnitee to
the Company. In the event that the Company fails to pay Expenses as incurred by the Indemnitee as required by this paragraph, Indemnitee may seek mandatory injunctive relief (including without limitation specific performance) from any court having
jurisdiction to require the Company to pay Expenses as set forth in this paragraph. If Indemnitee seeks mandatory injunctive relief pursuant to this paragraph, it shall not be a defense to enforcement of the Company’s obligations set forth in
this paragraph that Indemnitee has an adequate remedy at law for damages. 
 7. Notice and Other Indemnification
Procedures. 
 (a) Notice by Indemnitee. Promptly after receipt by the Indemnitee of notice of the commencement of or
the threat of commencement of any Proceeding, the Indemnitee shall, if the Indemnitee believes that indemnification with respect thereto may be sought from the Company under this Agreement, notify the Company in writing of the commencement or threat
of commencement thereof. 

  
 6 

 (b) Insurance. If the Company receives notice pursuant to Section 7(a) hereof of
the commencement of a Proceeding that may be covered under D&O Insurance then in effect, the Company shall give prompt notice of the commencement of such Proceeding to the insurers in accordance with the procedures set forth in the respective
policies. 
 (c) Defense. In the event the Company shall be obligated to pay the Expenses of any Proceeding against the
Indemnitee, the Company shall be entitled to assume the defense of such Proceeding, with counsel selected by the Company and approved by the Indemnitee (which approval shall not be unreasonably withheld), upon the delivery to the Indemnitee of
written notice of the Company’s election so to do. After delivery of such notice, and the retention of such counsel by the Company, the Company will not be liable to the Indemnitee under this Agreement for any fees of counsel subsequently
incurred by the Indemnitee with respect to the same Proceeding, provided that (i) the Indemnitee shall have the right to employ his or her own counsel in any such Proceeding at the Indemnitee’s expense; and (ii) the Indemnitee shall
have the right to employ his or her own counsel in any such Proceeding at the Company’s expense if (A) the Company has authorized the employment of counsel by the Indemnitee at the expense of the Company, (B) the Indemnitee shall
have reasonably concluded that there may be a conflict of interest between the Company and the Indemnitee in the conduct of any such defense, or (C) the Company shall not, in fact, have employed counsel to assume the defense of such Proceeding.
In addition to all the requirements above, if the Company has D&O Insurance, or other insurance, with a panel counsel requirement that may cover the matter for which indemnity is claimed by Indemnitee, then Indemnitee shall use such panel
counsel or other counsel approved by the insurers, unless there is an actual conflict of interest posed by representation by all such counsel, or unless and to the extent Company waives such requirement in writing. The Indemnitee and its
counsel shall provide reasonable cooperation with such insurer on request of the Company. 
 8. Right to Indemnification.

 (a) Right to Indemnification. In the event that Section 5(a) is inapplicable, the Company shall indemnify the
Indemnitee pursuant to this Agreement unless, and except to the extent that, it shall have been determined by one of the methods listed in Section 8(b) that the Indemnitee has not met the applicable standard of conduct required to entitle the
Indemnitee to such indemnification. 
 (b) Determination of Right to Indemnification. A determination of the
Indemnitee’s right to indemnification under this Section 8 shall be made at the election of the Board by (i) a majority vote of directors who are not parties to the Proceeding for which indemnification is being sought, even though
less than a quorum, or by a committee consisting of directors who are not parties to the Proceeding for which indemnification is being sought, who, even though less than a quorum, have been designated by a majority vote of the disinterested
directors, or (ii) if there are no such disinterested directors or if the disinterested directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to the Indemnitee. However, in the event
there has been a Change in Control, then the determination shall, at Indemnitee’s sole option, be made by Independent Counsel as in (b)(ii), above, with Indemnitee choosing the Independent Counsel subject to Company’s consent, such consent
not to be unreasonably withheld. 

  
 7 

 (c) Submission for Decision. As soon as practicable, and in no event later than
thirty (30) days after the Indemnitee’s written request for indemnification, the Board shall select the method for determining the Indemnitee’s right to indemnification. The Indemnitee shall cooperate with the person or persons or
entity making such determination with respect to the Indemnitee’s right to indemnification, including providing to such person, persons or entity, upon reasonable advance request, any documentation or information which is not privileged or
otherwise protected from disclosure and which is reasonably available to the Indemnitee and reasonably necessary to such determination. Any Independent Counsel or member of the Board shall act reasonably and in good faith in making a determination
regarding the Indemnitee’s entitlement to indemnification under this Agreement. 
 (d) Application to Court. If
(i) a claim for indemnification or advancement of Expenses is denied, in whole or in part, (ii) no disposition of such claim is made by the Company within ninety (90) days after the request therefore, (iii) the advancement of
Expenses is not timely made pursuant to Section 6 of this Agreement or (iv) payment of indemnification is not made pursuant to Section 5 of this Agreement, the Indemnitee shall have the right to apply to the Delaware Court of
Chancery, the court in which the Proceeding is or was pending, or any other court of competent jurisdiction, for the purpose of enforcing the Indemnitee’s right to indemnification (including the advancement of Expenses) pursuant to this
Agreement. 
 (e) Expenses Related to the Enforcement or Interpretation of this Agreement. The Company shall indemnify
the Indemnitee against all reasonable Expenses incurred by the Indemnitee in connection with any hearing or proceeding under this Section 8 involving the Indemnitee, and against all reasonable Expenses incurred by the Indemnitee in connection
with any other proceeding between the Company and the Indemnitee involving the interpretation or enforcement of the rights of the Indemnitee under this Agreement, if and to the extent the Indemnitee is successful. To the extent Indemnitee is awarded
relief on any Expense, that Expense shall be subject to 10% prejudgment interest from the date the invoice detailing that Expense was provided to the Company. 
 (f) In no event shall Indemnitee’s right to indemnification (apart from advancement of Expenses) be determined prior to a final adjudication in the Proceeding at issue if the Proceeding is both
ongoing, and of the nature to have a final adjudication. 
 (g) In any proceeding to determine Indemnitee’s right to
indemnification or advancement, Indemnitee shall be presumed to be entitled to indemnification or advancement, with the burden of proof on the Company to prove, by a preponderance of the evidence (or higher standard if required by relevant law) that
Indemnitee is not so entitled. 
 (h) Indemnitee shall be fully indemnified for those matters where, in the performance of his
duties for the Company, he relied in good faith upon the records of the Company and upon such information, opinions, reports or statements presented to the Company by any of the Company’s officers or employees, or committees of the board of
directors, or by any other person as to matters Indemnitee reasonably believed were within such other person’s professional or expert competence and who was selected with reasonable care by or on behalf of the Company. 

  
 8 

 (i) The knowledge or actions, or failure to act, or any director, officer, agent, or
employee of the Corporation, or the Corporation itself, shall not be imputed to Indemnitee for purposes of determining any rights hereunder. 
 9. Exceptions. Any other provision herein to the contrary notwithstanding, the Company shall not be obligated: 
 (a) Claims Initiated by Indemnitee. To indemnify or advance Expenses to the Indemnitee with respect to Proceedings or claims initiated or brought voluntarily by the Indemnitee and not by way of
defense, with a reasonable allocation where appropriate, unless (i) such indemnification is expressly required to be made by law, (ii) the Proceeding was authorized by the Board, (iii) such indemnification is provided by the Company,
in its sole discretion, pursuant to the powers vested in the Company under the General Corporation Law of Delaware or (iv) the Proceeding is brought to establish or enforce a right to indemnification under this Agreement or any other statute or
law or otherwise as required under Section 145 in advance of a final determination; 
 (b) Fees on Fees. To
indemnify the Indemnitee for any Expenses incurred by the Indemnitee with respect to any Proceeding instituted by the Indemnitee to enforce or interpret this Agreement, to the extent Indemnitee is not successful in such a Proceeding; 

(c) Unauthorized Settlements. To indemnify the Indemnitee under this Agreement for any amounts paid in settlement of a Proceeding
unless the Company consents to such settlement, which consent shall not be unreasonably withheld; 
 (d) Claims Under
Section 16(b). To indemnify the Indemnitee for Expenses and the payment of profits made from the purchase and sale (or sale and purchase) by the Indemnitee of securities of the Company within the meaning of Section 16(b) of the
Securities Exchange Act of 1934, as amended, or similar provisions of state statutory law or common law; or 
 (e) Payments
Contrary to Law. To indemnify or advance Expenses to the Indemnitee for which payment is prohibited by applicable law. 

10. Non-Exclusivity. The provisions for indemnification and advancement of Expenses set forth in this Agreement shall not be
deemed exclusive of any other rights which the Indemnitee may have under any provision of law, the Company’s Certificate of Incorporation or Bylaws, the vote of the Company’s stockholders or disinterested directors, other agreements, or
otherwise, both as to action in the Indemnitee’s official capacity and as to action in another capacity while occupying the Indemnitee’s position as an Agent of the Company. The Indemnitee’s rights hereunder shall continue after the
Indemnitee has ceased acting as an Agent of the Company and shall inure to the benefit of the heirs, executors and administrators of the Indemnitee. 
 11. Permitted Defenses. It shall be a defense to any action for which a claim for indemnification is made under this Agreement (other than an action brought to enforce a claim for Expenses pursuant
to Section 6 hereof, provided that the required undertaking has been tendered to the Company) that the Indemnitee is not entitled to indemnification because of the 

  
 9 

 
limitations set forth in Sections 4 and 9 hereof. Neither the failure of the Company (including its Board of Directors) or an Independent Counsel to have made a determination prior to the
commencement of such enforcement action that indemnification of the Indemnitee is proper in the circumstances, nor an actual determination by the Company (including its Board of Directors) or an Independent Counsel that such indemnification is
improper, shall be a defense to the action or create a presumption that the Indemnitee is not entitled to indemnification under this Agreement or otherwise. 
 12. Subrogation. In the event the Company is obligated to make a payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery under
any insurance policy or any other indemnity agreement covering the Indemnitee, who shall execute all documents reasonably required and take all action that may be necessary to secure such rights and to enable the Company effectively to bring suit to
enforce such rights (provided that the Company pays the Indemnitee’s costs and expenses of doing so), including without limitation by assigning all such rights to the Company or its designee to the extent of such indemnification or advancement
of Expenses. 
 13. Information Sharing. If the Indemnitee is the subject of or is implicated in any investigation,
whether formal or informal, by a government or regulatory entity or agency, the Company shall provide to Indemnitee any information provided to the investigating entity concerning the investigation; provided, that by executing this Agreement,
Indemnitee agrees to use such information solely in connection with the defense of such investigation and if Indemnitee is no longer serving as a Director or employed by the Corporation, Indemnitee shall at the Corporation’s request execute a
confidentiality agreement substantially in the form of the confidentiality agreement in effect while such Indemnitee was a Director or employed by the Corporation. 
 14. Primacy of Indemnification. The Company hereby acknowledges that the Indemnitee may have certain rights to indemnification, advancement of expenses or liability insurance provided by a
third-party investor and certain of its affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees that (i) it is the indemnitor of first resort, i.e., its obligations to the Indemnitee under this Agreement
and any indemnity provisions set forth in its Certificate of Incorporation, Bylaws or elsewhere (collectively, “Indemnity Arrangements”) are primary, and any obligation of the Fund Indemnitors to advance expenses or to provide
indemnification for the same expenses or liabilities incurred by the Indemnitee is secondary and excess, (ii) it shall advance the full amount of expenses incurred by the Indemnitee and shall be liable for the full amount of all expenses,
judgments, penalties, fines and amounts paid in settlement by or on behalf of the Indemnitee, to the extent legally permitted and as required by any Indemnity Arrangement, without regard to any rights the Indemnitee may have against the Fund
Indemnitors, and (iii) it irrevocably waives, relinquishes and releases the Fund Indemnitors from any claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind arising out of or relating to any
Indemnity Arrangement. The Company further agrees that no advancement or indemnification payment by any Fund Indemnitor on behalf of the Indemnitee shall affect the foregoing, and the Fund Indemnitors shall be subrogated to the extent of such
advancement or payment to all of the rights of recovery of the Indemnitee against the Company. The Company and the Indemnitee agree that the Fund Indemnitors are express third party beneficiaries of the terms of this Section 14. The Company, on
its own behalf and on behalf of its insurers to the extent allowed by the policies, waives subrogation rights against Indemnitee. 

  
 10 

 15. Survival of Rights. 

(a) All agreements and obligations of the Company contained herein shall continue during the period Indemnitee is an Agent of the Company
and shall continue thereafter so long as Indemnitee shall be subject to any possible claim or threatened, pending or completed Proceeding by reason of the fact that Indemnitee was serving in the capacity referred to herein. 

(b) The Company shall require any successor to the Company (whether direct or indirect, by purchase, merger, consolidation or otherwise)
to all or substantially all of the business or assets of the Company, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken
place. 
 16. Interpretation of Agreement. It is understood that the parties hereto intend this Agreement to be
interpreted and enforced so as to provide indemnification to the Indemnitee to the fullest extent permitted by law, including those circumstances in which indemnification would otherwise be discretionary. 

17. Severability. If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any
reason whatsoever, (i) the validity, legality and enforceability of the remaining provisions of the Agreement (including, without limitation, all portions of any paragraphs of this Agreement containing any such provision held to be invalid,
illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby, and (ii) to the fullest extent possible, the provisions of this Agreement (including, without limitation,
all portions of any paragraph of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that are not themselves invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested
by the provision held invalid, illegal or unenforceable and to give effect to Section 14 hereof. 
 18. Modification and
Waiver. No supplement, modification or amendment of this Agreement shall be binding unless it is in a writing signed by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver
of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. 
 19.
Notice. All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (a) upon delivery if delivered by hand to the party to whom such notice or other
communication shall have been directed, (b) if mailed by certified or registered mail with postage prepaid, return receipt requested, on the third business day after the date on which it is so mailed, (c) one business day after the
business day of deposit with a nationally recognized overnight delivery service, specifying next day delivery, with written verification of receipt, or (d) on the same day as delivered by confirmed facsimile transmission if delivered during
business hours or on the next successive business day if delivered by confirmed facsimile transmission after business hours. Addresses for notice to either party shall be as shown on the signature page of this Agreement, or to such other address as
may have been furnished by either party in the manner set forth above. 

  
 11 

 20. Governing Law. This Agreement shall be governed exclusively by and construed
according to the laws of the State of Delaware as applied to contracts between Delaware residents entered into and to be performed entirely within Delaware. This Agreement is intended to be an agreement of the type contemplated by
Section 145(f) of the General Corporation Law of Delaware. 
 21. Counterparts. This Agreement may be executed in
one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforcement is sought needs
to be produced to evidence the existence of this Agreement. 
 The parties hereto have entered into this Indemnity Agreement
effective as of the date first above written. 

 

			
	Indemnitee:
		
		 	
	  

	[                    ]
		 	
	Address:	 	  

		 	  

		
		 	
		 	

			
	The Company:
	
	ZELTIQ AESTHETICS, INC.
		
	By:	 	  

			
		
	Name:	 	  

			
		
	Title:	 	  

 

  
 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]